Arabic Arabic English English French French German German
dark

ImCheck Publishes Seminal Paper in Cell Reports Elucidating How Butyrophilins Activate Vγ9Vδ2 T cell Function Against Tumor Cells

ImCheck Therapeutics today announced the publication of preclinical data elucidating the fundamental role of butyrophilins (BTNs) in the activation of V gamma 9 V delta 2 (Vγ9Vδ2) T cells leading to an anti-tumor immune response in the peer-reviewed journal, Cell Reports Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

“This Is a Scandal”: Documents Reveal Obama’s EPA Approved Toxic Chemicals for Fracking in 2011

Next Post

Lung Therapeutics Announces Appointment of Sharon Morriss, PhD, as Senior Vice President of Clinical Development

Related Posts
Total
0
Share